Among short-lived diabetes treatments, a combo therapy lasts
By
Alicia Lasek
Nov 04, 2020
Dual treatment with the glucose-lowering drugs dapagliflozin and exenatide remains effective for patients with diabetes after two years of continual use, according to the results of a late-stage clinical...
Diabetes drugs under scrutiny
By
Elizabeth Newman
Apr 01, 2013
Diabetes medications Januvia and Byetta significantly increase the risk of pancreatic inflammation, according to Johns Hopkins University School of Medicine researchers.
Diabetics on Januvia, Byetta at risk for dangerous pancreatic inflammation, researchers find
By
McKnight's Staff
Mar 04, 2013
Johns Hopkins University School of Medicine researchers looked at 1,269 people who took at least one prescription diabetes drug between 2005-2008, comparing them to a control group of 1,269 diabetics who...